Essential blepharospasm is an idiopathic disorder of progressive involuntary spasms of the orbicularis oculi and upper facial muscles. It may occur in isolation or as part of a spectrum of dystonic movements of other facial, oral, mandibular, or cervical muscles. The condition usually presents in middle age and is more common in women than men. ' Of the 11 patients undergoing the orbicularis stripping procedure nine were female and two male, and their mean age was 64-4 years (range 51-78 years). Prior to surgery seven of the patients had undergone medical therapy. Six had been controlled with botulinum toxin injections for a mean period of 17 months until the injections were no longer effective or were required at too frequent intervals to be practical. Three had troublesome blepharospasm despite previous facial nerve avulsion. After protractor myectomy the mean follow-up was 23-7 months (range 1-80 months).
Eight (72%) of the 11 patients had acceptable control of blepharospasm throughout follow-up after the upper lid orbicularis stripping procedure alone. Three (27%) patients required further treatment for blepharospasm. This consisted of lower lid orbicularis stripping alone in one case, lower lid orbicularis stripping followed by botulinum toxin injections in the second case, and botulinum toxin injections alone in the third case.
After the orbicularis stripping procedure most ofthe patients had marked postoperative swelling and bruising, but this settled. Only one patient required corrective lid surgery for a lower lid ectropion, which followed lower lid orbicularis stripping. Three patients were treated for minor degrees of corneal exposure but only for a short time after surgery. One patient, who was known to have partial nasolacrimal duct obstruction prior to surgery, now has persistent epiphora thought to be due to the additional effect of reduced function of the orbicularis mediated lacrimal pump and is awaiting dacryocystorhinostomy.
The probability of recurrence of blepharospasm with time after facial nerve avulsion and orbicularis myectomy was plotted after KaplanMeier analysis (Fig 1) 81-8% in all controlled by orbicularis muscle surgery throughout the period of review. This is similar to the findings of other series.'3 14 However, since follow-up is much longer in the facial nerve avulsion group, and therefore recurrence more likely, Kaplan-Meier analysis is necessary to provide a more accurate comparison of the two groups (Fig 1) . After facial nerve avulsion 50% of patients had recurrence of disabling spasms within 15 months of surgery and only 25% had relief from spasms for more than two years. Other series have quoted recurrence rates of 35-40% at 15 months and 50-55% at two years,7 but this obviously depends on a highly subjective assessment by the patients.
After orbicularis myectomy relief is more prolonged, with a 50% recurrence rate not observed until almost 30 months after surgery and 55% of patients obtaining relief for more than two years. Myectomy appears to offer the longer relief, but both methods require adjunctive treatment to maintain relief from blepharospasm.
It is important to consider how successful each of these treatments was in combination with adjunctive therapy, medications, or toxin rather than in isolation. It is well known that such Orbicularis myoctomy 80 100
Figure Kaplan-Meier curve for probability ofrecurrence ofblepharospasm after surgery.
therapy is more successful after either facial nerve avulsion or myectomy.'5 All the patients who have required further treatment with botulinum toxin after myectomy have had a good response, and their spasms are well controlled. Following facial nerve avulsion this has also been true with the exception of three (6%) patients whose spasms were not well controlled and so underwent myectomy with good effect. Secondary effects of facial nerve avulsion that may require surgery include paralytic ectropion, epiphora, lagophthalmos, exacerbation of upper lid dermatochalasis, lip paresis, drooping of the mouth, collection of saliva, and a variable degree of loss of facial expression.8 13 A change in facial appearance is inevitable after this form of surgery, with drooping of the brows and ofthe corners ofthe mouth. However, after bilateral surgery the appearance of the face is symmetrical and fairly acceptable cosmetically. The loss of facial expression is obviously a serious consequence but one which was considered to be preferable to disabling blepharospasm by all the patients in this series, as has been the case in other series."
Secondary effects of myectomy are reported to be less than those of facial nerve avulsion,'3 and we found this to be the case. Those commonly described include considerable swelling and ecchymosis postoperatively, numbness of the forehead due to supraorbital nerve damage, chronic periorbital lymphoedema, exposure keratitis, and ectropion.
When the complications of the two forms of surgery are compared, myectomy appears to be the safer procedure. Only one of the 11 patients required surgical treatment for complications of myectomy (ectropion repair), whereas 20 of the 48 patients who underwent facial nerve avulsion required further surgical treatment for ectropion, brow or lid ptosis. This is similar to the findings of other series.8 In neither group did any patient suffer from severe corneal exposure, and though watering of the eyes was a common complaint in both groups only one patient was troubled sufficiently to consider lacrimal surgery.
Both groups ofpatients were of similar age and sex, and had similar treatment for blepharospasm prior to surgery. The decision as to whether myectomy or facial nerve avulsion was performed depended simply on which consultant they were referred to. In this series myectomy offered more prolonged relief from blepharospasm than facial nerve avulsion. Furthermore myectomy had fewer secondary effects, though no patient in either group suffered from severe corneal exposure or other major complication. The major disadvantage of myectomy is that it is a technically difficult and time consuming procedure, with the possibility of major blood loss. 12 13 In conclusion, we believe that botulinum toxin is the treatment of first choice in essential blepharospasm. If symptomatic spasms recur, surgery is justified and should not be deferred, as serious complications appear to be rare after either nerve avulsion or myectomy. In otherwise fit and healthy patients myectomy is the surgical treatment of first choice, because of its longer effect and fewer complications. However, facial Months after surgery nerve avulsion may still have a role as a primary procedure in the elderly or infirm because of its lower peroperative morbidity.
